Diffuse Myelinoclastic Sclerosis

Diffuse myelinoclastic sclerosis is a rare neurodegenerative disorder characterized by pseudotumoral demyelinating lesions. It is sometimes considered a variant of multiple sclerosis while others classify it a distinct disease. Find the latest research on diffuse myelinoclastic sclerosis here.

September 20, 2018
Case Report
Open Access

Advanced neuroimaging in Balo's concentric sclerosis: MRI, MRS, DTI, and ASL perfusion imaging over 1 year

Radiology Case Reports
Crystal Jing Jing YeoSteve H Fung
August 30, 2018
Open Access

Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis

Journal of Magnetic Resonance Imaging : JMRI
Biao XiangDmitriy A Yablonskiy
July 26, 2018
Open Access

Differences in Cortical Structure and Functional MRI Connectivity in High Functioning Autism

Frontiers in Neurology
Alessandra M PereiraFernando Cendes
March 21, 2020

Imaging of Fulminant Demyelinating Disorders of the Central Nervous System

Journal of Computer Assisted Tomography
Ahmed Abdel Khalek Abdel Razek, Nermeen A Elsebaie
June 9, 2018
Open Access

Brain Structural and Perfusion Signature of Amyotrophic Lateral Sclerosis With Varying Levels of Cognitive Deficit

Frontiers in Neurology
Dongchao ShenLiying Cui
September 14, 2018
Case Report

Recurrent schilder's disease

Multiple Sclerosis and Related Disorders
Anastasie M Dunn-Pirio, Christopher Eckstein
July 29, 2018

Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients

Journal of Neurology
G BalloySociété Francophone de la Sclérose en Plaques
October 27, 2018
Open Access

Differential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated Syndrome

Frontiers in Neurology
Ismail KoubiyrAurélie Ruet
June 20, 2018

The genotypic and phenotypic spectrum of PARS2-related infantile-onset encephalopathy

Journal of Human Genetics
Xiaomeng YinNan Li
October 5, 2018
Case Report

A case of primary angiitis of the central nervous system presenting with diffuse cerebral microbleeds and recurrent intracranial hemorrhage

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Xiaojuan HanYouting Lin
October 20, 2018
Case Report

Tactile enumeration: A case study of acalculia

Brain and Cognition
Zahira Z CohenAvishai Henik
July 10, 2018
Open Access

Quantitative MRI evaluation of glaucomatous changes in the visual pathway

PloS One
Mana FukudaToru Nakazawa
August 31, 2018
Open Access

What do we know about the pathology of gray matter in multiple sclerosis

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
N V Khachanova

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved
/feed-previews/diffuse-myelinoclastic-sclerosis/b1f21d33-174b-4ccc-9ed2-d276380009e5